Abstract
Sarcoidosis is a rare systemic inflammatory granulomatous disease with broad manifestation ranging from acute epileptic seizures to fatigue and pain syndromes that are subject to the organ involved. Delays in the diagnosis of sarcoidosis are attributed to the lack of a single diagnostic test or unified commonly used diagnostic criteria, and diagnosis based on exclusion of possible alternative diagnoses. We aim to systematically review the evidence about diagnostic delay in sarcoidosis to elucidate the causes and consequences of diagnostic delay, including people with sarcoidosis’ experiences. This will inform the development of interventions, tools, and health policies aiming to improve diagnostic efficiency and patients’ experiences of sarcoidosis.
Methods and analysis A systematic search of the literature will be conducted using PubMed/Medline, Scopus, and ProQuest databases, and sources of grey literature, up to 25th of May 2022, with no limitations on publication date. We will include all study types (qualitative, quantitative, and mixed methods) except review articles, examining diagnostic delay, incorrect diagnosis, missed diagnosis or slow diagnosis of all types of sarcoidosis across all age groups. We will also examine evidence of patients’ experiences associated with diagnostic delay. Only studies in English, German and Indonesian will be included. The outcomes we examine will be diagnostic delay time, patients’ experiences, and causes and consequences associated with diagnostic delay in sarcoidosis. Two people will independently screen the titles and abstracts of search results, and then the remaining full-text documents against the inclusion criteria. Disagreements will be resolved with a third reviewer until consensus is reached. Selected studies will be appraised using the Mixed Methods Appraisal Tool (MMAT). A meta-analysis and subgroup analysis of quantitative data will be conducted. Meta-aggregation methods will be used to analyse qualitative data. If there is insufficient data for these analyses, a narrative synthesis will be conducted.
Ethics and dissemination Ethical approval will not be required as no human recruitment or participation will be involved. Findings of the study will be disseminated through publications in peer-reviewed journals, conferences, and symposia.
Trial registration PROSPERO Registration number: CRD42022307236 URL of the PROSPERO registration: https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This review is part of the “Missed opportunities in clinical practice: Tools to enhance healthcare providers’ awareness and diagnosis of rare diseases in Australia” project funded by the Commonwealth represented by Department of Health Australia (Grant ID 4-G5ZN0T7). The funders had and will have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
Funding This review is part of the “Missed opportunities in clinical practice: Tools to enhance healthcare providers’ awareness and diagnosis of rare diseases in Australia” project funded by the Commonwealth represented by Department of Health Australia (Grant ID 4-G5ZN0T7).
The funders had and will have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing interests The authors have declared that no competing interests exist.
Data availability No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf
